中国中西医结合急救杂志
中國中西醫結閤急救雜誌
중국중서의결합급구잡지
INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE IN PRACTICE OF CRITICAL CARE MEDICINE
2013年
6期
357-361
,共5页
许德凤%郭东风%叶青山%刘文勋%张琴琴%赵蕾%丁薇%曹帆帆
許德鳳%郭東風%葉青山%劉文勛%張琴琴%趙蕾%丁薇%曹帆帆
허덕봉%곽동풍%협청산%류문훈%장금금%조뢰%정미%조범범
白细胞介素-32%炎症因子%大鼠%克雷伯杆菌肺炎
白細胞介素-32%炎癥因子%大鼠%剋雷伯桿菌肺炎
백세포개소-32%염증인자%대서%극뢰백간균폐염
Interleukin-32%Inflammatory factor%Rats%Klebsiella bacillus pneumonia
目的:观察白细胞介素-32(IL-32)在大鼠克雷伯杆菌肺炎中的变化,并探讨其意义。方法选择72只SD大鼠,按随机数字表法分为对照组、模型组和实验组,再按实验4 h和1、3、5 d分为4个亚组,每组6只。采用经气管注入0.3 mL细菌混悬液的方法建立大鼠克雷伯杆菌肺炎模型,实验组大鼠制模前腹腔注射IL-32抑制剂蛋白酶活化受体2(PAR2);于制模后不同时间点尾静脉取血观察各组大鼠血清IL-32、肿瘤坏死因子-α(TNF-α)、IL-6、IL-8水平的变化;取肺组织行苏木素-伊红(HE)染色,光镜下观察肺组织的病理学改变。结果与对照组比较,模型组IL-32、TNF-α、IL-8、IL-6随时间延长均逐渐升高,3 d时达峰值〔IL-32(ng/L):84.40±28.24比18.57±3.86,t=5.544,P=0.002;TNF-α(ng/L):79.27±14.64比17.82±3.86, t=9.994,P=0.000;IL-8(ng/L):55.85±10.90比16.66±3.76,t=8.544,P=0.000;IL-6(ng/L):56.65±2.57比28.48±2.11,t=19.693,P=0.000〕;PAR2预处理可使上述各指标均明显降低,3 d时与模型组比较差异有统计学意义〔IL-32(ng/L):54.13±6.68比84.40±28.24,t=2.560,P=0.046;TNF-α(ng/L):49.12±3.56比79.27±14.64,t=4.901,P=0.003;IL-8(ng/L):22.95±2.52比55.85±10.90,t=7.204,P=0.000;IL-6(ng/L):36.49±2.63比56.65±2.57,t=13.443,P=0.000〕。光镜下观察,实验组大鼠肺组织炎症改变较模型组有所减轻。结论 IL-32作为一种前炎症反应细胞因子,可诱导TNF-α、IL-6和IL-8的产生,抑制IL-32产生对克雷伯杆菌肺炎病情的进展有一定的作用。
目的:觀察白細胞介素-32(IL-32)在大鼠剋雷伯桿菌肺炎中的變化,併探討其意義。方法選擇72隻SD大鼠,按隨機數字錶法分為對照組、模型組和實驗組,再按實驗4 h和1、3、5 d分為4箇亞組,每組6隻。採用經氣管註入0.3 mL細菌混懸液的方法建立大鼠剋雷伯桿菌肺炎模型,實驗組大鼠製模前腹腔註射IL-32抑製劑蛋白酶活化受體2(PAR2);于製模後不同時間點尾靜脈取血觀察各組大鼠血清IL-32、腫瘤壞死因子-α(TNF-α)、IL-6、IL-8水平的變化;取肺組織行囌木素-伊紅(HE)染色,光鏡下觀察肺組織的病理學改變。結果與對照組比較,模型組IL-32、TNF-α、IL-8、IL-6隨時間延長均逐漸升高,3 d時達峰值〔IL-32(ng/L):84.40±28.24比18.57±3.86,t=5.544,P=0.002;TNF-α(ng/L):79.27±14.64比17.82±3.86, t=9.994,P=0.000;IL-8(ng/L):55.85±10.90比16.66±3.76,t=8.544,P=0.000;IL-6(ng/L):56.65±2.57比28.48±2.11,t=19.693,P=0.000〕;PAR2預處理可使上述各指標均明顯降低,3 d時與模型組比較差異有統計學意義〔IL-32(ng/L):54.13±6.68比84.40±28.24,t=2.560,P=0.046;TNF-α(ng/L):49.12±3.56比79.27±14.64,t=4.901,P=0.003;IL-8(ng/L):22.95±2.52比55.85±10.90,t=7.204,P=0.000;IL-6(ng/L):36.49±2.63比56.65±2.57,t=13.443,P=0.000〕。光鏡下觀察,實驗組大鼠肺組織炎癥改變較模型組有所減輕。結論 IL-32作為一種前炎癥反應細胞因子,可誘導TNF-α、IL-6和IL-8的產生,抑製IL-32產生對剋雷伯桿菌肺炎病情的進展有一定的作用。
목적:관찰백세포개소-32(IL-32)재대서극뢰백간균폐염중적변화,병탐토기의의。방법선택72지SD대서,안수궤수자표법분위대조조、모형조화실험조,재안실험4 h화1、3、5 d분위4개아조,매조6지。채용경기관주입0.3 mL세균혼현액적방법건립대서극뢰백간균폐염모형,실험조대서제모전복강주사IL-32억제제단백매활화수체2(PAR2);우제모후불동시간점미정맥취혈관찰각조대서혈청IL-32、종류배사인자-α(TNF-α)、IL-6、IL-8수평적변화;취폐조직행소목소-이홍(HE)염색,광경하관찰폐조직적병이학개변。결과여대조조비교,모형조IL-32、TNF-α、IL-8、IL-6수시간연장균축점승고,3 d시체봉치〔IL-32(ng/L):84.40±28.24비18.57±3.86,t=5.544,P=0.002;TNF-α(ng/L):79.27±14.64비17.82±3.86, t=9.994,P=0.000;IL-8(ng/L):55.85±10.90비16.66±3.76,t=8.544,P=0.000;IL-6(ng/L):56.65±2.57비28.48±2.11,t=19.693,P=0.000〕;PAR2예처리가사상술각지표균명현강저,3 d시여모형조비교차이유통계학의의〔IL-32(ng/L):54.13±6.68비84.40±28.24,t=2.560,P=0.046;TNF-α(ng/L):49.12±3.56비79.27±14.64,t=4.901,P=0.003;IL-8(ng/L):22.95±2.52비55.85±10.90,t=7.204,P=0.000;IL-6(ng/L):36.49±2.63비56.65±2.57,t=13.443,P=0.000〕。광경하관찰,실험조대서폐조직염증개변교모형조유소감경。결론 IL-32작위일충전염증반응세포인자,가유도TNF-α、IL-6화IL-8적산생,억제IL-32산생대극뢰백간균폐염병정적진전유일정적작용。
Objective To study the changes in interleukin-32 (IL-32) in rats with Klebsiella bacillus pneumonia and approach its significance. Methods Seventy-two Sprague-Dawley(SD)rats were divide into control group,model group and experimental group by the method of random digits table,then the experimental group was subdivided into 4 hours and 1,3 and 5 days experimental subgroups(each n=6). The rat model of Klebsiella bacillus pneumonia was established by injection of 0.3 mL Klebsiella bacterial suspension into the trachea. Before the establishment of the model in the experimental group,IL-32 inhibitory agent,protease activated receptor-2(PAR2) was injected into the abdominal cavity. After model establishment,at different time points,blood was collected via tail vein to observe the changes in serum levels of IL-32,tumor necrosis factor-α(TNF-α),IL-6 and IL-8 in all the groups. The lungs were removed and stained with hematoxylin-eosin(HE)method to investigate the histopathological changes of the lung tissues under the light microscope. Results Compared to the control group, with the prolongation of time the levels of IL-32,TNF-α,IL-8 and IL-6 were increased gradually in the model group,and reached their peaks at 3 days〔IL-32(ng/L):84.40±28.24 vs. 18.57±3.86,t=5.544,P=0.002;TNF-α(ng/L):79.27±14.64 vs. 17.82±3.86, t=9.994, P=0.000;IL-8(ng/L):55.85±10.90 vs. 16.66±3.76,t=8.544, P=0.000;IL-6(ng/L):56.65±2.57 vs. 28.48±2.11,t=19.693,P=0.000〕;PAR2 could inhibit above indexes significantly,there was statistical difference at 3 days compared with the model group〔IL-32(ng/L):54.13±6.68 vs. 84.40±28.24,t=2.560,P=0.046;TNF-α(ng/L):49.12±3.56 vs. 79.27±14.64,t=4.901,P=0.003;IL-8 (ng/L):22.95±2.52 vs. 55.85±10.90,t=7.204,P=0.000;IL-6(ng/L):36.49±2.63 vs. 56.65±2.57,t=13.443, P=0.000〕. Under the light microscope,the inflammatory changes in the lung tissue in experimental group were milder than those in the model group. Conclusion As a pro-inflammatory cytokine,IL-32 can induce the production of TNF-α,IL-6 and IL-8,and the inhibition of IL-32 production may play a role in suppression of the development of Klebsiella bacillus pneumonia.